Lasa Supergenerics (NSE:LASA, BOM:540702) expanded its production capacity for Albendazole USP through debottlenecking of existing infrastructure and installing new machinery at the unit, according to a Thursday bourse filing.
The veterinary API manufacturer invested around 10 million Indian rupees in the expansion, which will help meet the demand for Albendazole across domestic and international markets.